Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113403350A reveals a novel enzymatic route for high-purity acetylhydroxyproline, offering significant cost reduction and scalable manufacturing for the cosmetic industry.
Patent CN114958699A reveals a novel dual-enzyme co-expression strategy for ursodeoxycholic acid, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Patent CN105200076A reveals high-purity gamma-lactam production. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN104178533B details enzymatic synthesis of R-3-aminobutanol. Offers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN101285085A reveals a high-efficiency whole cell catalysis method for Adenosylmethionine, offering superior conversion rates and simplified purification for global supply chains.
Patent CN113528472B details a novel P450 BM3 mutant route for Trenbolone Acetate. Discover cost reduction in steroid manufacturing and high-purity intermediate supply strategies.
Patent CN111662889B discloses a novel ketoreductase mutant enabling efficient synthesis of Darunavir intermediates with high substrate loading and reduced costs.
Patent CN113564144A discloses lipase mutants enabling room temperature, water-phase asymmetric hydrolysis with >95% e.e., offering cost-effective pharmaceutical intermediate manufacturing.
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN107653238A reveals immobilized carbonyl reductase cells for high-yield statin intermediate production, offering significant supply chain stability and cost reduction advantages.
Patent CN108690836B details a mutated cyclohexanone monooxygenase for high-conversion esomeprazole synthesis, offering superior purity and scalability for API manufacturers.
Advanced patent CN101010289B details a streamlined synthesis for 4,5-diaminoshikimic acid derivatives. Discover cost-effective manufacturing and supply chain advantages for antiviral intermediates.
Novel Bacillus megaterium strain enables high-purity R-4-chloro-3-hydroxybutyrate production with reduced costs and environmental impact.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.
Patent CN110777125B details a novel Y127W mutant enzyme for high-concentration synthesis of chiral piperidine intermediates, offering significant cost reduction in API manufacturing.
Patent CN113322291A details an enzymatic route for high-purity chiral amino alcohols, offering cost-effective solutions for veterinary antibiotic manufacturing.